Huons Global Co. Ltd - Asset Resilience Ratio
Huons Global Co. Ltd (084110) has an Asset Resilience Ratio of 5.68% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 084110 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2010–2025)
This chart shows how Huons Global Co. Ltd's Asset Resilience Ratio has changed over time. See 084110 net asset quality score to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Huons Global Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Huons Global Co. Ltd market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩88.73 Billion | 5.68% |
| Total Liquid Assets | ₩88.73 Billion | 5.68% |
Asset Resilience Insights
- Limited Liquidity: Huons Global Co. Ltd maintains only 5.68% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Huons Global Co. Ltd Industry Peers by Asset Resilience Ratio
Compare Huons Global Co. Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Sam Chun Dang Pharm. Co. Ltd
KQ:000250 |
Pharmaceuticals | 4.82% |
|
ST Pharm Co.Ltd
KQ:237690 |
Pharmaceuticals | 7.72% |
|
NatureCell Co.Ltd
KQ:007390 |
Pharmaceuticals | 0.00% |
|
Oscotec Inc
KQ:039200 |
Pharmaceuticals | 65.38% |
|
Caregen Co.Ltd
KQ:214370 |
Pharmaceuticals | 4.58% |
|
Kolon Life Science Inc
KQ:102940 |
Pharmaceuticals | 1.22% |
|
Mezzion Pharma Co.Ltd
KQ:140410 |
Pharmaceuticals | 13.09% |
|
Komipharm International Co. Ltd
KQ:041960 |
Pharmaceuticals | 0.00% |
Annual Asset Resilience Ratio for Huons Global Co. Ltd (2010–2025)
The table below shows the annual Asset Resilience Ratio data for Huons Global Co. Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 6.40% | ₩99.76 Billion ≈ $67.61 Million |
₩1.56 Trillion ≈ $1.06 Billion |
-13.33pp |
| 2024-12-31 | 19.72% | ₩277.26 Billion ≈ $187.90 Million |
₩1.41 Trillion ≈ $952.79 Million |
-3.99pp |
| 2023-12-31 | 23.71% | ₩312.53 Billion ≈ $211.79 Million |
₩1.32 Trillion ≈ $893.17 Million |
-5.88pp |
| 2022-12-31 | 29.59% | ₩367.84 Billion ≈ $249.28 Million |
₩1.24 Trillion ≈ $842.44 Million |
+0.52pp |
| 2021-12-31 | 29.07% | ₩373.15 Billion ≈ $252.88 Million |
₩1.28 Trillion ≈ $869.98 Million |
+5.31pp |
| 2020-12-31 | 23.75% | ₩225.42 Billion ≈ $152.76 Million |
₩949.02 Billion ≈ $643.14 Million |
+11.33pp |
| 2019-12-31 | 12.42% | ₩92.21 Billion ≈ $62.49 Million |
₩742.15 Billion ≈ $502.95 Million |
-0.43pp |
| 2018-12-31 | 12.86% | ₩86.51 Billion ≈ $58.63 Million |
₩672.88 Billion ≈ $456.00 Million |
-2.83pp |
| 2017-12-31 | 15.68% | ₩95.70 Billion ≈ $64.85 Million |
₩610.15 Billion ≈ $413.49 Million |
-1.88pp |
| 2016-12-31 | 17.56% | ₩97.82 Billion ≈ $66.29 Million |
₩557.06 Billion ≈ $377.51 Million |
+15.57pp |
| 2015-12-31 | 1.99% | ₩6.25 Billion ≈ $4.24 Million |
₩314.13 Billion ≈ $212.88 Million |
-3.92pp |
| 2014-12-31 | 5.91% | ₩15.04 Billion ≈ $10.19 Million |
₩254.51 Billion ≈ $172.48 Million |
+3.99pp |
| 2013-12-31 | 1.92% | ₩3.96 Billion ≈ $2.68 Million |
₩206.22 Billion ≈ $139.76 Million |
-3.59pp |
| 2012-12-31 | 5.52% | ₩10.23 Billion ≈ $6.93 Million |
₩185.52 Billion ≈ $125.72 Million |
+4.19pp |
| 2010-12-31 | 1.33% | ₩1.88 Billion ≈ $1.27 Million |
₩141.76 Billion ≈ $96.07 Million |
-- |
About Huons Global Co. Ltd
Huons Global Co., Ltd. provides medical solutions for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and inj… Read more